Martin J. D’Souza

2.6k total citations
130 papers, 2.0k citations indexed

About

Martin J. D’Souza is a scholar working on Pharmaceutical Science, Immunology and Molecular Biology. According to data from OpenAlex, Martin J. D’Souza has authored 130 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pharmaceutical Science, 46 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Martin J. D’Souza's work include Immunotherapy and Immune Responses (33 papers), Advanced Drug Delivery Systems (29 papers) and Advancements in Transdermal Drug Delivery (26 papers). Martin J. D’Souza is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Advanced Drug Delivery Systems (29 papers) and Advancements in Transdermal Drug Delivery (26 papers). Martin J. D’Souza collaborates with scholars based in United States, Qatar and Ghana. Martin J. D’Souza's co-authors include Carl W. Oettinger, Rikhav P. Gala, Mohammad Nasir Uddin, Susu M. Zughaier, Ipshita Menon, Keegan Braz Gomes, Lipika Chablani, Priyal Bagwe, Rokon Uz Zaman and Grace V. Milton and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and The FASEB Journal.

In The Last Decade

Martin J. D’Souza

128 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin J. D’Souza United States 24 725 591 542 302 207 130 2.0k
Maytal Bivas‐Benita Israel 18 370 0.5× 484 0.8× 397 0.7× 198 0.7× 230 1.1× 29 1.5k
Kevin O. Kisich United States 17 254 0.4× 644 1.1× 714 1.3× 237 0.8× 251 1.2× 24 2.4k
Rajeev K. Tyagi India 26 748 1.0× 321 0.5× 615 1.1× 115 0.4× 105 0.5× 70 2.0k
Jie Tang China 21 330 0.5× 588 1.0× 463 0.9× 681 2.3× 221 1.1× 79 2.0k
Sarah Hook New Zealand 35 1.0k 1.4× 950 1.6× 1.5k 2.7× 267 0.9× 211 1.0× 116 3.5k
Eder Lilia Romero Argentina 29 525 0.7× 247 0.4× 744 1.4× 343 1.1× 58 0.3× 84 2.0k
María José Morilla Argentina 28 443 0.6× 226 0.4× 696 1.3× 334 1.1× 57 0.3× 69 1.8k
Satyanarayana Somavarapu United Kingdom 30 913 1.3× 272 0.5× 697 1.3× 142 0.5× 123 0.6× 79 2.3k
Kapil Khatri India 22 751 1.0× 330 0.6× 687 1.3× 111 0.4× 96 0.5× 47 1.5k
Femke Broere Netherlands 31 221 0.3× 1.3k 2.2× 1.2k 2.2× 224 0.7× 240 1.2× 105 3.0k

Countries citing papers authored by Martin J. D’Souza

Since Specialization
Citations

This map shows the geographic impact of Martin J. D’Souza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin J. D’Souza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin J. D’Souza more than expected).

Fields of papers citing papers by Martin J. D’Souza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin J. D’Souza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin J. D’Souza. The network helps show where Martin J. D’Souza may publish in the future.

Co-authorship network of co-authors of Martin J. D’Souza

This figure shows the co-authorship network connecting the top 25 collaborators of Martin J. D’Souza. A scholar is included among the top collaborators of Martin J. D’Souza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin J. D’Souza. Martin J. D’Souza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uddin, Mohammad Nasir, et al.. (2025). An intranasal quadruple variant vaccine approach using SARS-CoV-2 and influenza A: Delta, Omicron, H1N1and H3N2. International Journal of Pharmaceutics. 683. 126043–126043. 2 indexed citations
2.
Wong, Jennifer C., et al.. (2025). Microfluidics-Assisted Formulation of Polymeric Oxytocin Nanoparticles for Targeted Brain Delivery. Pharmaceutics. 17(4). 452–452. 2 indexed citations
4.
Bagwe, Priyal, Ipshita Menon, Keegan Braz Gomes, et al.. (2023). Gonococcal microparticle vaccine in dissolving microneedles induced immunity and enhanced bacterial clearance in infected mice. International Journal of Pharmaceutics. 642. 123182–123182. 8 indexed citations
5.
Chablani, Lipika, et al.. (2023). Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide. Vaccines. 11(3). 543–543. 1 indexed citations
7.
Gomes, Keegan Braz, Priyal Bagwe, Ipshita Menon, et al.. (2023). Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles. International Journal of Molecular Sciences. 24(13). 10612–10612. 10 indexed citations
9.
Kang, Sang‐Moo, et al.. (2022). Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity. Vaccines. 10(4). 584–584. 4 indexed citations
10.
11.
Uddin, Mohammad Nasir, et al.. (2021). Technology Update: Laser Ablation Technology for Transdermal Immunization. Journal of Vaccines & Vaccination. 1–4. 1 indexed citations
12.
Kang, Sang‐Moo, et al.. (2021). Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus. Vaccines. 9(11). 1324–1324. 14 indexed citations
13.
Zaman, Rokon Uz, et al.. (2018). Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin. International Journal of Pharmaceutics. 548(1). 698–706. 39 indexed citations
14.
Rizvi, Syed A. A., et al.. (2012). Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting. Journal of drug targeting. 21(1). 77–86. 34 indexed citations
15.
Pai, S. Balakrishna, et al.. (2009). Amphotericin B microspheres: A therapeutic approach to minimize toxicity while maintaining antifungal efficacy. Journal of Microencapsulation. 26(7). 580–587. 12 indexed citations
16.
Uddin, Mohammad Nasir, et al.. (2009). A methodology for quantitation and characterization of oligonucleotides in albumin microspheres. The Analyst. 134(7). 1483–1483. 13 indexed citations
17.
Nettey, Henry, et al.. (2007). In Vitro Antimicrobial Effect of Encapsulated Vancomycin on InternalizedStaphylococcus aureusWithin Endothelial Cells. Drug Development and Industrial Pharmacy. 33(2). 133–139. 8 indexed citations
18.
D’Souza, Martin J., et al.. (2005). Treatment of Experimental Septic Shock with Microencapsulated Antisense Oligomers to NF-κB. Journal of Interferon & Cytokine Research. 25(6). 311–320. 21 indexed citations
19.
Oettinger, Carl W. & Martin J. D’Souza. (2003). Microencapsulation of Tumor Necrosis Factor Oligomers: A New Approach to Proinflammatory Cytokine Inhibition. Journal of Interferon & Cytokine Research. 23(9). 533–543. 15 indexed citations
20.
D’Souza, Martin J., Carl W. Oettinger, & Grace V. Milton. (2000). Microspheres Containing Neutralizing Antibodies to Tumor Necrosis Factor-α and Interleukin-1β Protect Rats from Staphylococcus aureus -Induced Peritonitis. Journal of Interferon & Cytokine Research. 20(10). 907–913. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026